Abstract
Osteocytes are mechanosensory commander cells to regulate bone remodeling throughout the lifespan. While the osteocyte is known as a terminally differentiated cell derived from mesenchymal stem cell, the detailed mechanisms of cell-fate decision toward osteocyte differentiation still remain unclear. In this study, we fabricated three-dimensional (3D) self-organized spheroids using human mesenchymal stem cells (hMSCs). Under the osteogenesis induction medium, the spheroid culture model exerted the osteocyte-likeness within 2 days compared to a conventional 2D monolayer model. By using an inhibitor of actin polymerization, we showed an involvement of actin balancing in the osteocyte differentiation in the spheroid. Notably, we represented that the cell condensed condition acquired in the 3D spheroid culture model determined a differentiation fate of MSCs to osteocytes via actin balancing. Taken together, we suggest that our self-organized spheroid model can be utilized as a new in vitro model to represent the osteocyte differentiation process and further to recapitulate an in vitro ossification process.
Introduction
The bone undertakes continuous remodeling by osteoclasts and osteoblasts throughout the lifespan while its balance is modulated by mechanosensory commander cells, osteocytes (Robling and Bonewald, 2020; Adachi et al., 2009). From the view of developmental process, the ossification is initiated by mesenchymal condensation. In other words, the osteocyte is also known as a terminally differentiated bone cell derived from the mesenchymal stem cells (MSCs). The MSCs are referred to as multipluripotent progenitor cells capable of differentiation into skeletal tissues such as osteoblasts, chondrocytes, adipocytes, myocytes (Caplan, 1991; Pittenger et al., 2019, 1999). After the osteoblasts produce the bone matrices such as collagen type I and alkaline phosphatase during the bone remodeling process (Parfitt, 2001; Rutkovskiy et al., 2016), it is known that they encounter one of fates; 1) to become bone-lining cells, 2) to become osteocytes embedded in the bone, and 3) to undertake apoptosis (Manolagas, 2000; Robling and Bonewald, 2020).
For both osteoblast differentiation and bone mineralization studies, many researches have established a gold standard protocol to induce in vitro osteogenesis using chemical osteogenesis induction (OI) supplements such as ascorbic acid and β-glycerophosphate (Buttery et al., 2001; Coelho and Fernandes, 2000). On the other hand, in vitro osteocyte differentiation has been also attempted by many studies. After the osteoblast precursor cells were subjected to a long period of cultivation in the OI culture medium on the culture dish, a three-dimensional dome-shape of bone-like nodule was formed (Bhargava et al., 1988; Kawai et al., 2019; Mechiche Alami et al., 2016). Although the osteocyte-like cells were eventually observed inside the nodule after several weeks to months, the efficient method to achieve the direct osteocyte differentiation derived from pre-osteoblast cells or stem cells has not been established since the osteocyte-like cells were randomly shown in the nodule after such a long cultivation. Moreover, it still remains difficulties for primary osteocytes to culture in vitro and further to maintain the cellular morphology and functions for a long period of time, so that a new in vitro osteocyte model is required to be established with a novel efficient method. After achieving this, it will help unraveling the unknown mechanisms of cell-fate decision toward osteocytes.
In previous studies, our group has elucidated the effect of three-dimensional culture for pre-osteoblast cells on the osteocyte differentiation (Kim et al., 2020; Kim and Adachi, 2019). Compared to the conventional monolayer model, the pre-osteoblast cells in the form of scaffold-free spheroid model rendered the osteocyte-likeness within 2 days in the absence of the OI supplements. In this study, we fabricated the 3D spheroid culture model reconstructed by the MSCs and evaluated its osteocyte differentiation capability. By using the MSC spheroid model, we attempted to elucidate the mechanism of cell-fate decision of MSCs toward osteocytes and also to recapitulate the in vitro ossification process derived from the mesenchymal condensation.
Materials and Methods
Cell culture
Human bone marrow-derived MSCs (passage 2) were acquired from PromoCell (Germany) and RIKEN BRC (Japan). The cells were maintained in the basal medium which is low glucose-Dulbecco’s Modified Eagle Medium (Gibco) supplemented with 10% fetal bovine serum (Gibco) and 1% antibiotic-antimycotic (Gibco) solution in a humidified incubator at 37□ under 5% CO2 condition. We carried out the cell passaging every 2 – 3 days when the cell confluency became 80 – 90%. For experiments, the cells from passage 4 up to 12 were used. To prepare an osteogenic induction (OI) medium, we utilized high glucose-Dulbecco’s Modified Eagle Medium (Gibco) containing 50 μM ascorbic acid (Wako), 10 mM β-glycerophosphate (Sigma), and 100 nM dexamethasone (Nacalai Tesque). To prepare for 2D monolayer samples, 200,000 cells were subcultured on a 35 mm diameter culture dish to become confluent after 2-day incubation. This study was approved by the Ethics Committee of Institute for Frontier Life and Medical Sciences, Kyoto University (Clinical Protocol No. 89).
Fabrication of spheroids
Based on the previous study (Kim et al., 2020), we fabricated self-organized spheroids using hMSCs on the Nunclon Sphera 96-well round-bottom plate (ThermoFisher). 2,500 cells were subcultured on the round-bottom plate to fabricate the spheroids and incubated for 2, 4 or 7 days in the presence or absence of the OI medium depending on the aims of each experiments.
Real time-PCR
To measure mRNA expressions in the spheroid and monolayer reconstructed by hMSCs, we conducted real-time PCR. After the samples were rinsed with PBS once, they are immediately lysed with Isogen II (Nippon Gene). According to the manufacturer’s protocol, RNA extraction and cDNA synthesis were carried out using PureLink RNA Mini kit (Invitrogen) and Transcriptor Universal cDNA Master (Roche), respectively. For the real-time PCR, we used PowerUp SYBR Green Master Mix (ThermoFisher) while all the PCR primers were designed as shown in Table 1. Nanog, Oct4, and Sox2 were used as undifferentiated stem cell markers. For osteoblast markers, we examined mRNA expressions of runt-related transcription factor 2 (Runx2), alkaline phosphatase (Alpl), and type I collagen, alpha 1 chain (Col1a1). To distinguish osteocytes, we utilized osteopontin (Opn), phosphate regulating endopeptidase homolog X-linked (Phex), and sclerostin (Sost). While SRY-box transcription factor 9 (Sox9) and aggrecan (Acan) were used as chondrocyte markers, type X collagen, alpha 1 chain (Col10a1) and matrix metallopeptidase 13 (Mmp13) were examined as hypertrophic chondrocyte markers. For adipocyte markers, we utilized peroxisome proliferator activated receptor gamma (Pparg) and CCAAT enhancer binding protein alpha (Cebpa). All the mRNA expressions were normalized to a reference gene, glyceraldehyde-phosphate dehydrogenase (Gapdh) and measured by using the 2−ΔΔCT method.
Staining
The spheroids were collected and fixed in 4% paraformaldehyde (PFA). After fixation, the samples were permeabilized with 0.1% triton X-100 in PBS for 30 min and washed with PBS 3 times. For immunostaining, non-specific binding during staining was blocked with PBS containing 4% bovine serum albumin at room temperature for 1 h. Then, we added the anti-SOST antibody (Sigma) and incubated at room temperature for 1 h. After washing with PBS 3 times, the samples were treated with the Alexa Flour 488 secondary antibody (Invitrogen), Alexa Fluor 546 Phalloidin (Invitrogen), and DAPI (Sigma) at room temperature for 1 h. After washing with PBS 3 times, the samples were observed by the FLUOVIEW FV3000 (Olympus). For G-actin (globular) and F-actin (fibrous) staining, the samples were treated with the Deoxyribonuclease I (DNase I), Alexa Fluor 488 conjugate (Invitrogen) and Alexa Fluor 546 Phalloidin (Invitrogen), respectively, and counterstained with DAPI (Sigma) at room temperature for 15 min. After washing with PBS 3 times, the stained samples were mounted on the glass slides for visualization.
Statistical analysis
The statistical significance was assessed by Student’s t-test, F-test, or ANOVA followed by Tukey’s honestly significant difference (HSD) post-hoc test (with α = 0.05). P-values less than 0.05 were considered to be significant.
Result
MSC spheroid with osteogenic induction supplements up-regulated osteocyte markers within 2 days
As described in Fig. 1(A), the spheroids reconstructed by hMSCs were incubated in the osteogenic induction (OI) medium for 2 days. In Fig. 1(B), the spheroid has about 185 μm diameter at 2-day. To evaluate gene expression changes in the spheroid compared to the monolayer, we carried out real-time PCR in Fig. 1(C). After 2-day incubation, the relative mRNA expression in the spheroid for stem cell markers were up-regulated compared to that in the monolayer; Nanog (22.6-fold change; p < 0.05), Oct4 (9.7-fold change; p < 0.005), and Sox2 (30.4-fold change; p < 0.05). Regarding osteoblast markers, there was no significant mRNA expression change in Runx2 (1.70-fold change), while both Alpl (0.41-fold change; p < 0.005) and Col1a1 (0.21-fold change; p < 0.005) mRNA expressions were down-regulated in the spheroid. On the other hand, the relative mRNA expressions for osteocyte markers in the spheroids compared to the monolayer were highly up-regulated; Opn (28.4-fold change; p < 0.05), Phex (18.4-fold change; p < 0.005), and Sost (21.7-fold change; p < 0.05). To examine the protein level expression of osteocyte marker, we conducted the SOST immunostaining in Fig. 1(D) since the SOST is known as a marker of mature osteocytes. As a result, the SOST expression (green) in the protein level was detected entirely inside the spheroid after 2-day incubation. Moreover, F-actin was expressed strongly on the surface of the spheroid compared to the inner part.
Up-regulated osteocyte markers in the spheroid were prolonged after 7 days
To investigate the long-term persistence of gene expressions for osteocyte markers in the spheroid, we performed the longer experiment, 7-day, as shown in Fig.2 (A). The spheroid at 7-day in Fig. 2(B) became smaller compared to 2-day spheroid (48.9% reduction; p < 0.005). In Fig. 2 (C), the mean values of projected area of spheroid at 2-day and 7-day were 25,900 μm2 and 12,700 μm2, respectively. In Fig. 2(D), we conducted real-time PCR to examine the gene expression changes between 2-day and 7-day spheroid. Consequently, the stem cell markers in the 7-day spheroid were up-regulated compared to the 2-day spheroid; Nanog (15.9-fold change; p = 0.07), Oct4 (12.8-fold change; p < 0.05), and Sox2 (12.7-fold change; p = 0.26). Osteoblast markers were non-significantly modulated; Runx2 (2.63-fold change; p = 0.18), Alpl (8.44-fold change; p = 0.09), and Col1a1 (0.68-fold change; p = 0.12). Regarding osteocyte markers, while early osteocyte marker, Opn (0.86-fold change; p = 0.75), was not modulated, it up-regulated the mature osteocyte markers in the 7-day spheroid including Phex (18.5-fold change; p < 0.05) and Sost (10.0-fold change; p < 0.005). Immunostaining results in Fig. 2(E) represented that the SOST expression was entirely expressed in the 7-day spheroid
Structural effect achieved in 3D spheroid compared to 2D monolayer promoted stem cell, osteocyte, and hypertrophic chondrocyte markers
As described in Fig. 3(A), the spheroids were incubated in the basal medium in the absence of OI medium in order to elucidate the structural effect achieved in the 3D spheroid culture compared to the 2D monolayer condition, without the chemical supplements. In Fig. 3(B), we measured the gene expression changes in stem cell, osteoblast, and osteocyte markers. As a result, all the stem cell markers were significantly up-regulated in both 2-day and 7-day spheroid compared to 2-day monolayer, corresponding to the previous experiments. Particularly, the stem cell markers in the spheroid were further up-regulated after 7-day incubation. Regarding the osteoblast markers, there was significant up-regulations in the monolayer model, whereas those markers in the spheroid exerted a different trend. Especially, the Col1a1 mRNA expressions were significantly down-regulated at both 2-day and 7-day. In the spheroid model, all the osteocyte markers were up-regulated at 2-day and 7-day. Particularly, mRNA expression of early osteocyte marker, Opn, in 2-day spheroid was higher than that in 7-day spheroid, whereas the mRNA expressions of matured osteocyte markers involving Phex and Sost in 7-day spheroid was greater than that in 2-day spheroid.
Since the differentiation of hMSCs was not chemically induced into a certain cell lineage in this experiment, we also examined the gene expression change in chondrocyte, hypertrophic chondrocyte, and adipocyte markers. In Fig. 3(C), there was no significant changes in the osteocyte gene expression in the monolayer model. Regarding chondrocyte markers, both Sox9 and Acan mRNA expressions were up-regulated in the monolayer condition after 7-day incubation. In the spheroid, however, Acan mRNA expression was greatly suppressed at both 2-day and 7-day incubation although Sox9 mRNA expression was slightly increased. On the other hand, hypertrophic chondrocyte markers, such as Col10a1 and Mmp13, were greatly up-regulated in the form of spheroid compared to the monolayer. For adipose markers, the adipogenesis master gene, Pparg, was greatly down-regulated in the spheroid although mRNA expression of the metabolic action of insulin marker, Cebpa, was up-regulated in the spheroid. On the other hand, both Pparg and Cebpa mRNA expressions were increased in the monolayer condition after 7-day incubation.
Cell condensed condition in the 3D spheroid structure sustained the osteocyte differentiation
To elucidate the effect of cell condensation achieved in the 3D spheroid structure on the osteocyte differentiation, we introduced another model which the 3D spheroids in the ultra-low attachment dish at 2-day incubation were transferred to a normal culture dish as described in Fig. 4(A). Immediate after the spheroid was subcultured on the normal culture dish, the spheroids initiated to attach on the dish in Fig 4(B), and then the cells dissociated from the spheroid spread over the dish. After the extra 2-day incubation on the normal culture dish, the spheroid at 2-day lost its 3D structure and became like 2D model in Fig. 4(C), termed sph-mono model. We then examined their gene expression levels in the sph-mono model compared to 4-day monolayer and spheroid using real-time PCR in Fig. 4(D). Similar to 2-day cultivation results in the previous experiment, 4-day spheroid had higher gene expression levels in the stem cell and osteocyte markers than 4-day monolayer, whereas the mRNA expressions of osteoblast markers such as Alpl and Col1a1 in the spheroid were suppressed compared to the monolayer. On the other hand, those up-regulated markers for stem cell and osteocytes were down-regulated in the sph-mono model, which indicate that the up-regulations of stem cell and osteocyte markers were depending on the cell condensed condition acquired from the 3D spheroid structure. Regarding osteoblast markers, there was no significant change in the sph-mono model compared to the spheroid.
Cytochalasin D facilitated the osteocyte differentiation in the spheroid by actin depolymerization
To reveal mechanisms for the osteocyte differentiation evoked in the 3D spheroid structure, we utilized an actin polymerization inhibitor, cytochalasin D. During fabrication of spheroid, we added 1 μM of cytochalasin D as described in Fig. 5(A). Compared to the spheroid with DMSO in Fig. 5(B), the size of spheroid treated with cytochalasin D became bigger as shown in Fig. 5(C). In Fig. 5(D), the mean values of projected area of spheroid in the presence of DMSO and cytochalasin D became 23,500 μm2 and 31,300 μm2, respectively (133% increase; p < 0.005). In Fig. 5(E), we carried out F-actin/G-actin staining using phalloidin and DNase I to examine the changes in the actin balancing. By addition of cytochalasin D in the spheroid, the F-actin represented among the cells in the spheroid was delocalized. Moreover, the spheroid treated with cytochalasin D exerted greater G-actin expressions compared to the spheroid with DMSO. In Fig. 5(F), we then conducted real-time PCR to examine the mRNA expression changes in the spheroid by addition of inhibitor. Among the stem cell markers, adding cytochalasin D significantly up-regulated Sox2 mRNA expression; Nanog (1.15-fold change), Oct4 (1.13-fold change), and Sox2 (1.68-fold change; p < 0.05). Moreover, osteoblast markers were modulated by cytochalasin D; Runx2 (1.40-fold change; p < 0.005), Alpl (2.95-fold change; p < 0.05), and Col1a1 (0.82-fold change; p < 0.05). Particularly, addition of cytochalasin D up-regulated the osteocyte mRNA expressions; Opn (3.80-fold change; p < 0.05), Phex (1.15-fold change), Sost (1.24-fold change; p < 0.05). Hence, actin depolymerization by cytochalasin D in the spheroid up-regulated the osteocyte gene expression levels in the spheroid.
Discussion
Our group has studied the osteocyte differentiation acquired from the 3D culture system. In the previous studies, we showed that the osteocyte differentiation of pre-osteoblast cells was facilitated in the 3D scaffold-free culture system (Kim and Adachi, 2019; Kim et al., 2020; Kim and Adachi, 2020). Although we revealed that cell condensed condition is significant for the pre-osteoblast cells to undergo the osteocyte differentiation, it is still unclear whether or not the osteocyte differentiation can be further evoked from the mesenchymal stem cells that recapitulate the in vitro bone development process. In this study, we assumed that the 3D spheroid culture reconstructed by hMSCs enables to recapitulate the mesenchymal condensation process during the ossification. By using hMSCs, we fabricated self-organized spheroids and evaluated its osteocyte-likeness in vitro.
Under the OI medium, the hMSC spheroids were chemically induced to differentiate into the osteogenic lineage. As a result of real-time PCR and SOST immunostaining in Figs 1 and 2, the cells in the spheroid successfully rendered osteocyte-likeness within 2 days while the osteocyte-likeness was further prolonged up to 7 days. Furthermore, the osteoblast markers were greatly suppressed in the spheroid compared to the monolayer condition. The results obtained with the hMSCs in the present study corresponded to the previous studies using the murine pre-osteoblast cells, MC3T3-E1 (Kim and Adachi, 2019; Kim and Adachi, 2020). Moreover, the spheroid also exerted the up-regulations in stem cell markers. The increase in stem cell markers in the spheroid culture were also reported from other studies using stem cells (Cheng et al., 2012; Guo et al., 2014; Zhou et al., 2017). While the osteoblast differentiation in the monolayer condition is actively proceeded, the stemness were relatively maintained in the spheroid culture, so that the stem cell gene expressions were relatively up-regulated in the spheroid culture.
We then conducted the experiment with the basal medium for 2 and 7 days in the absence of OI supplements in order to investigate the independent structural effect in the 3D spheroid culture against the 2D monolayer culture. Interestingly, the differentiation induction of hMSCs had distinguished trends depending on the cultivation condition. In the monolayer condition, the hMSCs were likely to undertake the osteoblast, chondrocyte, and adipocyte differentiation randomly because of the absence of specific differentiation induction mediums. The result suggested that the monolayer condition seems to be a suitable condition to conduct the osteoblast, chondrocyte, and adipocyte differentiation studies as conducted in other studies for several decades. Since no certain chemical supplements were utilized, the hMSCs were thought to differentiate into those cells randomly. While the differentiation processes into osteoblast, chondrocyte, and adipocyte were undertaken on the monolayer, the spheroid condition had relatively greater gene expressions in osteocyte and hypertrophic chondrocyte markers as well as stem cell markers. During the endochondral ossification process, it is known that the bone is replaced from the cartilage via hypertrophic chondrocytes (Aghajanian and Mohan, 2018). The transient up-regulations of osteocyte and hypertrophic chondrocyte markers in the spheroid model might mimic the certain event of ossification process in vitro which is initiated from the mesenchymal condensation in vivo during the bone development process. Regarding the stem cell markers, the increase in stem cell gene expressions were observed, corresponding to the previous experiment using the OI medium in Fig. 1, which indicates that the spheroid culture for the hMSC relatively maintained its stemness compared to the monolayer condition, whereas the cells in the monolayer model is likely to differentiate and commit to some lineages even without certain chemical supplements.
To investigate the cell condensed effect achieved by the 3D spheroid, we transferred the spheroid to the normal culture dish, causing that the 3D spheroid spread over and became like monolayer condition, termed sph-mono model (the cells dissociated from the 3D spheroid). In terms of gene expression changes in the sph-mono model compared to 4-day spheroid and monolayer, the up-regulated osteocyte mRNA expressions as well as stemness marker in the spheroids were diminished after the spheroid lost the condensed condition. The results suggested that the cell condensed condition is essential for the hMSCs to differentiate into osteocytes and further to retain its osteocyte-likeness. In other words, the monolayer condition is not a suitable cell cultural environment for osteocyte related studies. This is why only limited number of in vitro osteocytic model were available since many studies attempted to undertake osteocyte differentiation on the monolayer condition. Hence, we hereby highlighted the significance of cell condensation condition for osteocytogenesis.
In order to reveal the mechanism in the facilitated osteocyte differentiation in the spheroid structure, the involvement of actin balancing was examined. In this study, cytochalasin D was utilized to inhibit the actin polymerization in the spheroid. As a result, cytochalasin D successfully delocalized F-actin in the spheroid, resulting in the increase in the size of spheroid. The prevention of F-actin polymerization by cytochalasin D eventually promoted osteocyte mRNA expressions in the spheroid. With regard to osteoblast differentiation on the conventional 2D monolayer condition, the actin balancing is involved in the osteoblast differentiation of human bone marrow-derived MSCs (Chen et al., 2015). On the other hand, our results first highlighted the involvement of actin balancing for the osteocyte differentiation of hMSCs. As illustrated in Fig. 6, this study suggested that the osteocyte differentiation can be achieved by weakened F-actin formation in the spheroid compared to the monolayer, whereas the generation of the tight F-actin on the monolayer model evoked the osteoblast differentiation of hMSCs as well as bone mineralization as shown in many other studies. For the stemness markers, actin depolymerization in the stem cells is known to promote their pluripotent states (Yu et al., 2018), which corresponds to our results. Based on this inhibitor experiment using the spheroid model, we first showed that the actin balancing is involved in the osteocyte differentiation induction acquired by the spheroid culture.
As many studies reported, the osteoblasts undergo the bone mineralization process where they are two-dimensionally arranged on the bone matrix, which is reconstructed in the conventional 2D monolayer condition for a long period of cultivation time, from several weeks to several months. During the in vitro bone formation studies using the 2D model, the osteoblast precursor cells in the confluent monolayer condition eventually forms the 3D dome-shape of bone nodules after a long experiment over several weeks (Bhargava et al., 1988). Eventually, osteocyte-like cells were found in the mineralized nodule (Kawai et al., 2019). Throughout our present study using the 3D spheroid culture model, we suggested a new insight that the osteocyte differentiation can be triggered by the 3D cell condensed condition of osteoblast precursor cells within a short period of time at a certain remodeling site. It might indicate that a group of cells in the bone nodule are subjected to the cell condensed condition, so that the osteocyte differentiation is acquired after the osteoblast precursor cells are confronted with the cell condensed condition. This explanation might also imply that the osteoblasts in the bone become osteocytes when they encountered the condensed condition at the remodeling site in vivo. For the cells in the condensed condition, they became three-dimensionally surrounded by cells and their extracellular matrices, so that formation of actin filaments is thought to be greatly suppressed. Hence, the osteocyte might not be differentiated from the mature osteoblasts, but directly differentiated from the osteoblast precursor cells in the cell condensed condition. Consequently, the cell condensed condition plays a significant role to determine the cellular differentiation fate of MSCs into the osteocytes.
In this study, the 3D spheroid reconstructed by MSCs under the OI medium exerted the osteocyte-likeness within 2 days. Notably, we first suggested the significance of the environmental factor to determine the MSC differentiation fate to osteocytes or osteoblasts, such as cell condensed condition acquired from the 3D culture beyond the chemically induced supplements. Moreover, we investigated the structural effect on MSC differentiations, which provides a suitable strategy of the cultural model for certain cell lineage studies. In the future, our 3D spheroid culture model can be utilized to represent the osteocytes and further to recapitulate an in vitro ossification process, becoming a new in vitro model as “bone organoid”.
Acknowledgement
We would like to thank Junko Sunaga for providing technical supports. This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (20H00659, 20K20181, and 19K23604), Advanced Research and Development Programs for Medical Innovation (AMED-CREST), by elucidation of mechanobiological mechanisms and their application to the development of innovative medical instruments and technologies from Japan Agency for Medical Research and Development (AMED) (JP20gm0810003), and by the acceleration program for intractable diseases research utilizing disease-specific iPS cells from AMED (JP19bm0804006).